This report contains market size and forecasts of Tysabri (natalizumab) Drug in global, including the following market information:
Global Tysabri (natalizumab) Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Tysabri (natalizumab) Drug Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Tysabri (natalizumab) Drug companies in 2020 (%)
The global Tysabri (natalizumab) Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Tysabri (natalizumab) Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tysabri (natalizumab) Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Tysabri (natalizumab) Drug Market Segment Percentages, By Type, 2020 (%)
Multiple Sclerosis
Crohn's Disease
Global Tysabri (natalizumab) Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Tysabri (natalizumab) Drug Market Segment Percentages, By Application, 2020 (%)
Hospital
Drugs Stores
Global Tysabri (natalizumab) Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Tysabri (natalizumab) Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tysabri (natalizumab) Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Tysabri (natalizumab) Drug revenues share in global market, 2020 (%)
Key companies Tysabri (natalizumab) Drug sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Tysabri (natalizumab) Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Tysabri (natalizumab) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tysabri (natalizumab) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tysabri (natalizumab) Drug Overall Market Size
2.1 Global Tysabri (natalizumab) Drug Market Size: 2021 VS 2027
2.2 Global Tysabri (natalizumab) Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Tysabri (natalizumab) Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Tysabri (natalizumab) Drug Players in Global Market
3.2 Top Global Tysabri (natalizumab) Drug Companies Ranked by Revenue
3.3 Global Tysabri (natalizumab) Drug Revenue by Companies
3.4 Global Tysabri (natalizumab) Drug Sales by Companies
3.5 Global Tysabri (natalizumab) Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Tysabri (natalizumab) Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Tysabri (natalizumab) Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tysabri (natalizumab) Drug Players in Global Market
3.8.1 List of Global Tier 1 Tysabri (natalizumab) Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Tysabri (natalizumab) Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tysabri (natalizumab) Drug Market Size Markets, 2021 & 2027
4.1.2 Multiple Sclerosis
4.1.3 Crohn's Disease
4.2 By Type - Global Tysabri (natalizumab) Drug Revenue & Forecasts
4.2.1 By Type - Global Tysabri (natalizumab) Drug Revenue, 2016-2021
4.2.2 By Type - Global Tysabri (natalizumab) Drug Revenue, 2022-2027
4.2.3 By Type - Global Tysabri (natalizumab) Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Tysabri (natalizumab) Drug Sales & Forecasts
4.3.1 By Type - Global Tysabri (natalizumab) Drug Sales, 2016-2021
4.3.2 By Type - Global Tysabri (natalizumab) Drug Sales, 2022-2027
4.3.3 By Type - Global Tysabri (natalizumab) Drug Sales Market Share, 2016-2027
4.4 By Type - Global Tysabri (natalizumab) Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tysabri (natalizumab) Drug Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Drugs Stores
5.2 By Application - Global Tysabri (natalizumab) Drug Revenue & Forecasts
5.2.1 By Application - Global Tysabri (natalizumab) Drug Revenue, 2016-2021
5.2.2 By Application - Global Tysabri (natalizumab) Drug Revenue, 2022-2027
5.2.3 By Application - Global Tysabri (natalizumab) Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Tysabri (natalizumab) Drug Sales & Forecasts
5.3.1 By Application - Global Tysabri (natalizumab) Drug Sales, 2016-2021
5.3.2 By Application - Global Tysabri (natalizumab) Drug Sales, 2022-2027
5.3.3 By Application - Global Tysabri (natalizumab) Drug Sales Market Share, 2016-2027
5.4 By Application - Global Tysabri (natalizumab) Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Tysabri (natalizumab) Drug Market Size, 2021 & 2027
6.2 By Region - Global Tysabri (natalizumab) Drug Revenue & Forecasts
6.2.1 By Region - Global Tysabri (natalizumab) Drug Revenue, 2016-2021
6.2.2 By Region - Global Tysabri (natalizumab) Drug Revenue, 2022-2027
6.2.3 By Region - Global Tysabri (natalizumab) Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Tysabri (natalizumab) Drug Sales & Forecasts
6.3.1 By Region - Global Tysabri (natalizumab) Drug Sales, 2016-2021
6.3.2 By Region - Global Tysabri (natalizumab) Drug Sales, 2022-2027
6.3.3 By Region - Global Tysabri (natalizumab) Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Tysabri (natalizumab) Drug Revenue, 2016-2027
6.4.2 By Country - North America Tysabri (natalizumab) Drug Sales, 2016-2027
6.4.3 US Tysabri (natalizumab) Drug Market Size, 2016-2027
6.4.4 Canada Tysabri (natalizumab) Drug Market Size, 2016-2027
6.4.5 Mexico Tysabri (natalizumab) Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Tysabri (natalizumab) Drug Revenue, 2016-2027
6.5.2 By Country - Europe Tysabri (natalizumab) Drug Sales, 2016-2027
6.5.3 Germany Tysabri (natalizumab) Drug Market Size, 2016-2027
6.5.4 France Tysabri (natalizumab) Drug Market Size, 2016-2027
6.5.5 U.K. Tysabri (natalizumab) Drug Market Size, 2016-2027
6.5.6 Italy Tysabri (natalizumab) Drug Market Size, 2016-2027
6.5.7 Russia Tysabri (natalizumab) Drug Market Size, 2016-2027
6.5.8 Nordic Countries Tysabri (natalizumab) Drug Market Size, 2016-2027
6.5.9 Benelux Tysabri (natalizumab) Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Tysabri (natalizumab) Drug Revenue, 2016-2027
6.6.2 By Region - Asia Tysabri (natalizumab) Drug Sales, 2016-2027
6.6.3 China Tysabri (natalizumab) Drug Market Size, 2016-2027
6.6.4 Japan Tysabri (natalizumab) Drug Market Size, 2016-2027
6.6.5 South Korea Tysabri (natalizumab) Drug Market Size, 2016-2027
6.6.6 Southeast Asia Tysabri (natalizumab) Drug Market Size, 2016-2027
6.6.7 India Tysabri (natalizumab) Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Tysabri (natalizumab) Drug Revenue, 2016-2027
6.7.2 By Country - South America Tysabri (natalizumab) Drug Sales, 2016-2027
6.7.3 Brazil Tysabri (natalizumab) Drug Market Size, 2016-2027
6.7.4 Argentina Tysabri (natalizumab) Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tysabri (natalizumab) Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Tysabri (natalizumab) Drug Sales, 2016-2027
6.8.3 Turkey Tysabri (natalizumab) Drug Market Size, 2016-2027
6.8.4 Israel Tysabri (natalizumab) Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Tysabri (natalizumab) Drug Market Size, 2016-2027
6.8.6 UAE Tysabri (natalizumab) Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Biogen
7.1.1 Biogen Corporate Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Tysabri (natalizumab) Drug Major Product Offerings
7.1.4 Biogen Tysabri (natalizumab) Drug Sales and Revenue in Global (2016-2021)
7.1.5 Biogen Key News
8 Global Tysabri (natalizumab) Drug Production Capacity, Analysis
8.1 Global Tysabri (natalizumab) Drug Production Capacity, 2016-2027
8.2 Tysabri (natalizumab) Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Tysabri (natalizumab) Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tysabri (natalizumab) Drug Supply Chain Analysis
10.1 Tysabri (natalizumab) Drug Industry Value Chain
10.2 Tysabri (natalizumab) Drug Upstream Market
10.3 Tysabri (natalizumab) Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tysabri (natalizumab) Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Tysabri (natalizumab) Drug in Global Market
Table 2. Top Tysabri (natalizumab) Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Tysabri (natalizumab) Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Tysabri (natalizumab) Drug Revenue Share by Companies, 2016-2021
Table 5. Global Tysabri (natalizumab) Drug Sales by Companies, (K Units), 2016-2021
Table 6. Global Tysabri (natalizumab) Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Tysabri (natalizumab) Drug Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Tysabri (natalizumab) Drug Product Type
Table 9. List of Global Tier 1 Tysabri (natalizumab) Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tysabri (natalizumab) Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Tysabri (natalizumab) Drug Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Tysabri (natalizumab) Drug Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Tysabri (natalizumab) Drug Sales (K Units), 2016-2021
Table 15. By Type - Global Tysabri (natalizumab) Drug Sales (K Units), 2022-2027
Table 16. By Application - Global Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Tysabri (natalizumab) Drug Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Tysabri (natalizumab) Drug Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Tysabri (natalizumab) Drug Sales (K Units), 2016-2021
Table 20. By Application - Global Tysabri (natalizumab) Drug Sales (K Units), 2022-2027
Table 21. By Region - Global Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Tysabri (natalizumab) Drug Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Tysabri (natalizumab) Drug Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Tysabri (natalizumab) Drug Sales (K Units), 2016-2021
Table 25. By Region - Global Tysabri (natalizumab) Drug Sales (K Units), 2022-2027
Table 26. By Country - North America Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Tysabri (natalizumab) Drug Sales, (K Units), 2016-2021
Table 29. By Country - North America Tysabri (natalizumab) Drug Sales, (K Units), 2022-2027
Table 30. By Country - Europe Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Tysabri (natalizumab) Drug Sales, (K Units), 2016-2021
Table 33. By Country - Europe Tysabri (natalizumab) Drug Sales, (K Units), 2022-2027
Table 34. By Region - Asia Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Tysabri (natalizumab) Drug Sales, (K Units), 2016-2021
Table 37. By Region - Asia Tysabri (natalizumab) Drug Sales, (K Units), 2022-2027
Table 38. By Country - South America Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Tysabri (natalizumab) Drug Sales, (K Units), 2016-2021
Table 41. By Country - South America Tysabri (natalizumab) Drug Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Tysabri (natalizumab) Drug Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Tysabri (natalizumab) Drug Sales, (K Units), 2022-2027
Table 46. Biogen Corporate Summary
Table 47. Biogen Tysabri (natalizumab) Drug Product Offerings
Table 48. Biogen Tysabri (natalizumab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Tysabri (natalizumab) Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 50. Global Tysabri (natalizumab) Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 51. Global Tysabri (natalizumab) Drug Production by Region, 2016-2021 (K Units)
Table 52. Global Tysabri (natalizumab) Drug Production by Region, 2022-2027 (K Units)
Table 53. Tysabri (natalizumab) Drug Market Opportunities & Trends in Global Market
Table 54. Tysabri (natalizumab) Drug Market Drivers in Global Market
Table 55. Tysabri (natalizumab) Drug Market Restraints in Global Market
Table 56. Tysabri (natalizumab) Drug Raw Materials
Table 57. Tysabri (natalizumab) Drug Raw Materials Suppliers in Global Market
Table 58. Typical Tysabri (natalizumab) Drug Downstream
Table 59. Tysabri (natalizumab) Drug Downstream Clients in Global Market
Table 60. Tysabri (natalizumab) Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Tysabri (natalizumab) Drug Segment by Type
Figure 2. Tysabri (natalizumab) Drug Segment by Application
Figure 3. Global Tysabri (natalizumab) Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Tysabri (natalizumab) Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Tysabri (natalizumab) Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Tysabri (natalizumab) Drug Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Tysabri (natalizumab) Drug Revenue in 2020
Figure 9. By Type - Global Tysabri (natalizumab) Drug Sales Market Share, 2016-2027
Figure 10. By Type - Global Tysabri (natalizumab) Drug Revenue Market Share, 2016-2027
Figure 11. By Type - Global Tysabri (natalizumab) Drug Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Tysabri (natalizumab) Drug Sales Market Share, 2016-2027
Figure 13. By Application - Global Tysabri (natalizumab) Drug Revenue Market Share, 2016-2027
Figure 14. By Application - Global Tysabri (natalizumab) Drug Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Tysabri (natalizumab) Drug Sales Market Share, 2016-2027
Figure 16. By Region - Global Tysabri (natalizumab) Drug Revenue Market Share, 2016-2027
Figure 17. By Country - North America Tysabri (natalizumab) Drug Revenue Market Share, 2016-2027
Figure 18. By Country - North America Tysabri (natalizumab) Drug Sales Market Share, 2016-2027
Figure 19. US Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Tysabri (natalizumab) Drug Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Tysabri (natalizumab) Drug Sales Market Share, 2016-2027
Figure 24. Germany Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 25. France Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Tysabri (natalizumab) Drug Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Tysabri (natalizumab) Drug Sales Market Share, 2016-2027
Figure 33. China Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 37. India Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Tysabri (natalizumab) Drug Revenue Market Share, 2016-2027
Figure 39. By Country - South America Tysabri (natalizumab) Drug Sales Market Share, 2016-2027
Figure 40. Brazil Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Tysabri (natalizumab) Drug Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Tysabri (natalizumab) Drug Sales Market Share, 2016-2027
Figure 44. Turkey Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Tysabri (natalizumab) Drug Revenue, (US$, Mn), 2016-2027
Figure 48. Global Tysabri (natalizumab) Drug Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Tysabri (natalizumab) Drug by Region, 2020 VS 2027
Figure 50. Tysabri (natalizumab) Drug Industry Value Chain
Figure 51. Marketing Channels
Biogen